These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6628806)

  • 41. Assessment of liver function using fasting bile salt concentrations in psoriasis prior to and during methotrexate therapy.
    Lawrence CM; Strange RC; Summerly R; Scriven AJ; Elmahallawy M; Wood A; Fletcher PJ; Beckett GJ
    Clin Chim Acta; 1983 Apr; 129(3):341-51. PubMed ID: 6851172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of erythrodermic and pustulous psoriasis with a combination of methotrexate and etretinate].
    Allegue Rodriguez F; Sendagorta Gomendio E; Freire Murgueytio P; Moreno Izquierdo R; Ledo Pozueta A
    Med Cutan Ibero Lat Am; 1988; 16(1):43-9. PubMed ID: 2967409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Azaribine therapy for psoriasis. Evaluation of potential effects on the liver and other organ systems.
    Keefer RA; Roenigk HH; Hawk WA
    Arch Dermatol; 1975 Jul; 111(7):853-6. PubMed ID: 1173747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liver biopsies from psoriatics treated with methotrexate.
    Ho MS; Cheah E; Tham SN; Teh LB; Ng HS; Thirumoorthy S
    Ann Acad Med Singap; 1986 Apr; 15(2):210-4. PubMed ID: 3752896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Guidelines on the use of methotrexate in psoriasis].
    Carretero G; Puig L; Dehesa L; Carrascosa JM; Ribera M; Sánchez-Regaña M; Daudén E; Vidal D; Alsina M; Muñoz-Santos C; López-Estebaranz JL; Notario J; Ferrandiz C; Vanaclocha F; García-Bustinduy M; Taberner R; Belinchón I; Sánchez-Carazo J; Moreno JC;
    Actas Dermosifiliogr; 2010 Sep; 101(7):600-13. PubMed ID: 20858386
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short-term methotrexate therapy in psoriasis: a study of 197 patients.
    Kumar B; Saraswat A; Kaur I
    Int J Dermatol; 2002 Jul; 41(7):444-8. PubMed ID: 12121564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methotrexate.
    Weinstein GD
    Ann Intern Med; 1977 Feb; 86(2):199-204. PubMed ID: 319725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The aminopyrine breath test, an inadequate early indicator of methotrexate-induced liver disease in patients with psoriasis.
    Williams CN; McCauley D; Malatjalian DA; Turnbull GK; Ross JB
    Clin Invest Med; 1987 Mar; 10(2):54-8. PubMed ID: 3581546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparison of RePUVA and aromatic retinoid Ro 10-9359 with methotrexate in severe forms of psoriasis].
    Mashkilleysson AL; Mashkilleysson NA
    Hautarzt; 1983 May; 34(5):229-30. PubMed ID: 6862887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver biopsies upsilon liver scans in methotrexate-treated patients with psoriasis.
    Geronemus RG; Auerbach R; Tobias H
    Arch Dermatol; 1982 Sep; 118(9):649-51. PubMed ID: 7114866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis.
    Baughman RP; Koehler A; Bejarano PA; Lower EE; Weber FL
    Arch Intern Med; 2003 Mar; 163(5):615-20. PubMed ID: 12622609
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methotrexate therapy of psoriasis. Effect and side effects with particular reference to hepatic changes. A survey.
    Nyfors A
    Dan Med Bull; 1980 Apr; 27(2):74-96. PubMed ID: 7000451
    [No Abstract]   [Full Text] [Related]  

  • 53. [Etretinate: pro and con. Risk-benefit analysis of systemic retinoid therapy in psoriasis and recent developments: free aromatic acid, arotinoids].
    Gollnick H; Orfanos CE
    Hautarzt; 1985 Jan; 36(1):2-9. PubMed ID: 3156105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liver ultrastructure in psoriatics related to methotrexate therapy. 2. Findings in bile ducts from 11 methotrexate treated psoriatics and 2 controls.
    Hopwood D; Nyfors A
    Acta Pathol Microbiol Scand A; 1977 Nov; 85(6):801-11. PubMed ID: 602767
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A case of centrolobular toxic necrosis of the liver due to aromatic retinoid--Tigason (Ro 10-9359).
    Thune P; Mørk NJ
    Dermatologica; 1980; 160(6):405-8. PubMed ID: 7389973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methotrexate pharmacokinetics in psoriatic patients developing hepatic fibrosis.
    Jones SK; Aherne GW; Campbell MJ; White JE
    Arch Dermatol; 1986 Jun; 122(6):666-9. PubMed ID: 3717976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A prospective study of the effects of weekly oral methotrexate on liver biopsy.
    Warin AP; Landells JW; Levene GM; Baker H
    Br J Dermatol; 1975 Sep; 93(3):321-7. PubMed ID: 1103936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in liver histology during methotrexate therapy of psoriasis correlated to the concentration of methotrexate and folate in erythrocytes.
    Hendel J; Poulsen H; Nyfors B; Nyfors A
    Acta Pharmacol Toxicol (Copenh); 1985 Apr; 56(4):321-6. PubMed ID: 4024960
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Australasian Psoriasis Collaboration view on methotrexate for psoriasis in the Australasian setting.
    Rademaker M; Gupta M; Andrews M; Armour K; Baker C; Foley P; Gebauer K; George J; Rubel D; Sullivan J
    Australas J Dermatol; 2017 Aug; 58(3):166-170. PubMed ID: 27402434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fine structural changes in the liver of methotrexate-treated psoriatics.
    Horvath E; Saibil FG; Kovacs K; Kerenyi NA; Ross RC
    Digestion; 1978; 17(6):488-502. PubMed ID: 710735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.